federal_register: 2026-01817
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01817 | Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP | Proposed Rule | This request for information seeks input from the public on whether any additions or modifications are needed to the safe harbor regulations under the Federal anti-kickback statute or the exceptions to the civil monetary penalty provision prohibiting inducements to beneficiaries (the "Beneficiary Inducements CMP") for emerging direct-to-consumer ("DTC") sales programs established by pharmaceutical manufacturers, including those that will be available through TrumpRx. | 2026-01-29 | 2026 | 1 | https://www.federalregister.gov/documents/2026/01/29/2026-01817/medicare-and-state-health-care-programs-fraud-and-abuse-request-for-information-regarding-the | https://www.govinfo.gov/content/pkg/FR-2026-01-29/pdf/2026-01817.pdf | Health and Human Services Department; Inspector General Office, Health and Human Services Department | 221,245 | This request for information seeks input from the public on whether any additions or modifications are needed to the safe harbor regulations under the Federal anti-kickback statute or the exceptions to the civil monetary penalty provision prohibiting... |